Editorial
Published on 27 Sep 2023
Editorial: Global excellence in inflammatory diseases: Latin America 2021
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1278212
- 1,347 views
- Frontiers in Immunology
- Inflammation
- Articles
Type at least 3 characters
4,005 articles
General Commentary
Published on 27 Sep 2023
Commentary: Targeting chemoattractant chemokine (C–C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1279782
- 1,482 views
Original Research
Published on 26 Sep 2023
Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1251750
- 9,990 views
- 15 citations
Original Research
Published on 26 Sep 2023
A hub gene signature as a therapeutic target and biomarker for sepsis and geriatric sepsis-induced ARDS concomitant with COVID-19 infection
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1257834
- 6,022 views
- 7 citations
Mini Review
Published on 26 Sep 2023
The role of perivascular adipose tissue-secreted adipocytokines in cardiovascular disease
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1271051
- 4,663 views
- 12 citations
Original Research
Published on 25 Sep 2023
Spatial proteomics identifies a spectrum of immune dysregulation in acquired bone marrow failure syndromes
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1213560
- 4,683 views
Original Research
Published on 25 Sep 2023
Myeloid-derived suppressor cells exacerbate poly(I:C)-induced lung inflammation in mice with renal injury and older mice
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1243851
- 2,775 views
- 2 citations
Original Research
Published on 25 Sep 2023
MicroRNA-510 mediated negative regulation of Caveolin-1 in fibroblasts promotes aggressive tumor growth
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1116644
- 2,226 views
- 2 citations
Original Research
Published on 25 Sep 2023
Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1233514
- 5,287 views
- 9 citations
Original Research
Published on 22 Sep 2023
Cardiovascular impairment in Shiga-toxin-2-induced experimental hemolytic–uremic syndrome: a pilot study
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1252818
- 3,124 views
- 2 citations
Original Research
Published on 22 Sep 2023
ß1-adrenergic blockers preserve neuromuscular function by inhibiting the production of extracellular traps during systemic inflammation in mice
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1228374
- 3,038 views
- 1 citation
Review
Published on 22 Sep 2023
New insight into the role of fibroblasts in the epithelial immune microenvironment in the single-cell era
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1259515
- 6,132 views
- 5 citations
Review
Published on 21 Sep 2023
Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1213473
- 17,027 views
- 23 citations
Review
Published on 21 Sep 2023
Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1150661
- 8,226 views
- 12 citations
Original Research
Published on 21 Sep 2023
Identification of cuproptosis-related subtypes, characterization of immune microenvironment infiltration, and development of a prognosis model for osteoarthritis
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1178794
- 5,440 views
- 6 citations
Original Research
Published on 21 Sep 2023
Pulmonary exacerbations in early cystic fibrosis lung disease are marked by strong modulation of CD3 and PD-1 on luminal T cells
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1194253
- 2,614 views
- 1 citation